A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
This protocol describes the viral-mediated ectopic expression of Neurod1 following cortical ischemic stroke. Neurod1 is delivered (1) using the Cre-Flex AAV system in wild-type mice during the subacute phase post-stroke (7 days) and (2) using a single AAV vector in conditional reporter mice during the chronic phase post-stroke (21 days).
Ectopic expression of neurogenic factors in vivo has emerged as a promising approach for replacing lost neurons in disease models. The use of neural basic helix-loop-helix (bHLH) transcription factors via non-propagating virus-like particle systems, including retrovirus, lentivirus, and adeno-associated virus (AAV), has been extensively reported. For in vivo experiments, AAVs are increasingly used due to their low pathogenicity and potential for translatability. This protocol describes two AAV systems for investigating the ectopic expression of transcription factors in transduced cells post-ischemic stroke. In both systems, Neurod1 expression is controlled by the short GFAP (gfaABC(1)D) promoter, which is upregulated in reactive astrocytes post-stroke as well as in endogenous neurons when combined with neurogenic factor expression. In the ischemic stroke model described, focal ischemia is induced by injecting endothelin-1 (ET-1) into the motor cortex of mice, creating a lesion surrounded by reactive GFAP-expressing astrocytes and surviving neurons. Intracerebral injections of AAV are performed to ectopically induce the expression of Neurod1 in the subacute (7 days) and chronic (21 days) phases post-stroke. Within weeks following AAV injection, a significantly higher number of neurons among transduced cells are identified in mice ectopically expressing Neurod1 compared to mice receiving AAV control viruses. The AAV-based strategies used replicated observed outcomes of increased numbers of neurons expressing the reporter gene in a model of mild-to-moderate cortical stroke. This protocol establishes a standard platform for exploring the effects of ectopic expression of transcription factors delivered with AAV-based systems, contributing to the understanding of neurogenic factor expression in the context of stroke.
Stroke is a leading cause of disability worldwide1. A stroke happens when blood flow to the brain is disrupted. This can occur either through a hemorrhagic stroke (~15% of cases), where a blood vessel in the brain bursts, or through an ischemic stroke, where blood flow to the brain is blocked1. Ischemic strokes are most prevalent and account for ~85% of stroke cases1. A stroke reduces the delivery of glucose and oxygen to the brain, leading to swift neuronal cell death and impaired neural function.
Ischemic stroke leads to the loss of cells within minutes in the core of....
This protocol was approved by the Animal Care Committee at the University of Toronto and adheres to the Guide to the Care and Use of Experimental Animals (2nd Edition, Canadian Council on Animal Care, 2017). For this study, wild-type (C57BL/6J) and transgenic tdTom-Cre reporter (B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J)22 mouse strains were used. Mice were 7-9 weeks old and included both males and females. Details of the reagents and equipment used are listed in th.......
To examine the cellular outcomes of short GFAP (gfaABC(1)D) promoter driven, ectopic Neurod1 expression in wild-type (C57BL/6J) and in transgenic tdTom-Cre reporter strains (specifically, B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J)22 two AAV5-based systems were utilized in ET-1 stroke injured mice (Figure 1A-C). In a subacute model of stroke, Neurod1 was packaged in the Cre-Flex AAV system and deliver.......
This protocol details two AAV systems and mouse models for investigating the ectopic expression of Neurod1 in the context of a mild-moderate ET-1 cortical stroke model. A number of critical steps relating to the ET-1 stroke are important to consider for the reproducibility and consistency of the injury. Burr holes must be carefully drilled without puncturing the dura mater to prevent unintentional surgical injury. It is important to use consistent landmarks, in this case bregma, to ensure a similar region of int.......
This work was supported by the Heart and Stroke Foundation, Ontario Institute of Regenerative Medicine, Canada First Research Excellence Fund (Medicine by Design, MbD), and Connaught Innovation Award (University of Toronto).
....Name | Company | Catalog Number | Comments |
#77 Drill Bit (.018”) | David Kopf Instruments | 8177 | |
AAV5-GFAP(0.7)-mNeurod1-2A-iCre | Vector Biolabs | ||
Anti-NeuN Antibody (rabbit) | Millipore Sigma | ABN78 | |
C57BL/6 Mice | Charles River | 027 | |
Chlorhexidine Solution | Partnar | PCH-020 | |
Cryostat | Thermo Scientific | HM525 NX | |
Endothelin 1 | Millipore Sigma | 05-23-3800-0.5MG | |
Feather Safety Razor Microtome Blades | Fisher Scientific | 12-631P | |
Fisherbrand Cover Glasses: Rectangles | Fisher Scientific | 12-545M | |
Fluorescence Mounting Medium | Agilent Technologies | S3023 | |
Hamilton Syringe | Hamilton Company | 7634-01 | |
High Speed Stereotaxic Drill | David Kopf Instruments | 1474 | |
Metacam Solution (Meloxicam) | Boehringer Ingelheim | ||
O.C.T Compound | Fisher Scientific | 23-730-571 | |
pAAV2/5-GFAP-iCre | Vector Builder | P190924-1001suq | |
Polyderm Ointment USP | TARO | 2181908 | |
Polysorb suture | Covidien | GL-881 | |
Stereotaxic Instruments | David Kopf Instruments | Model 902 | |
Superfrost Plus Microscope Slides, white | Fisherbrand | 12-550-15 | |
tdTomato Reporter Mice | The Jackson Laboratory | 007914 | |
V-1 Tabletop Laboratory Animal Anesthesia System | VetEquip | 901806 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved